Clinical trial
Randomized,Controlled,Multicenter Study of Autologous Tumor Lysate-pulsed Dendritic and Cytokine-induced Killer Cells(Ag-D-CIK) Combined With Chemotherapy for Gastric Cancer.
NCT02215837 is registered in ClinicalTrials.gov with Shenzhen Hornetcorn Bio-technology Company, LTD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized,Controlled,Multicenter Study of Autologous Tumor Lysate-pulsed Dendritic and Cytokine-induced Killer Cells(Ag-D-CIK) Combined With Chemotherapy for Gastric Cancer.
- Lead sponsor
- Shenzhen Hornetcorn Bio-technology Company, LTD
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- August 31, 2014
- Completion date
- May 31, 2018
- Enrollment
- 40 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
digestive system neoplasms, gastric cancer, gastrointestinal diseases, gastrointestinal neoplasms, neoplasms